MAPT and Alzheimer disease: Cerebral perfusion, an indication of blood supply to tissue, is a potential early biomarker of AD and its alteration may appear earlier in AD than other hallmark pathological changes, such as beta-amyloid (Aβ) deposition, hyperphosphorylated tau accumulation, and widespread brain atrophy [41, 42].